Competitive Sports Participation for Athletes with Cardiovascular Abnormalities:...
A groundbreaking advancement in the field of microscopy, particularly Brillouin ...
Repurposing a widely used blood pressure medication for the treatment of Attenti...
In a groundbreaking development that bridges the realms of artificial intelligen...
Acid-reducing medications known as proton pump inhibitors (PPIs) have become sta...
A group of former executives from health communications firm Inizio Evoke have l...
Biogen has bolstered its research and development efforts by securing an agreeme...
The U.S. Food and Drug Administration (FDA) has approved Romvimza (vimseltinib) ...
The U.S. Food and Drug Administration (FDA) has approved Penmenvy, a vaccine for...
As Sanofi and Regeneron await the FDA decision, a legal dispute between the part...
HMRI has signed a memorandum of understanding (MoU) with Novartis Australia for ...
The US FDA has granted fast track designation to Rznomics' RZ-001 for the treatm...
Ono’s therapy Romvimza is administered twice-weekly compared to Daiichi Sankyo’s...
Oncology studies present unique challenges when it comes to participant treatmen...
Clinical trial complexity has significantly increased in the past decade. How ca...
E. Merck KG board of partners has announced the appointment of new CEOs to Merck...
